| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |